FI970765A0 - Mellanprodukter av dinukleotid- och oligonukliatidanaloger - Google Patents

Mellanprodukter av dinukleotid- och oligonukliatidanaloger

Info

Publication number
FI970765A0
FI970765A0 FI970765A FI970765A FI970765A0 FI 970765 A0 FI970765 A0 FI 970765A0 FI 970765 A FI970765 A FI 970765A FI 970765 A FI970765 A FI 970765A FI 970765 A0 FI970765 A0 FI 970765A0
Authority
FI
Finland
Prior art keywords
oligonuclide
dinucleotide
analogues
intermediates
oligonuclide analogues
Prior art date
Application number
FI970765A
Other languages
English (en)
Finnish (fi)
Other versions
FI970765A (sv
Inventor
Anthony David Baxter
Roger John Taylor
Stephen Paul Collingwood
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI970765A0 publication Critical patent/FI970765A0/sv
Publication of FI970765A publication Critical patent/FI970765A/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI970765A 1994-09-03 1997-02-24 Mellanprodukter av dinukleotid- och oligonukliatidanaloger FI970765A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9417746A GB9417746D0 (en) 1994-09-03 1994-09-03 Chemical compounds
PCT/GB1995/001955 WO1996008503A1 (en) 1994-09-03 1995-08-17 Intermediates for dinucleotide and oligonucleotide analogues

Publications (2)

Publication Number Publication Date
FI970765A0 true FI970765A0 (sv) 1997-02-24
FI970765A FI970765A (sv) 1997-04-25

Family

ID=10760791

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970765A FI970765A (sv) 1994-09-03 1997-02-24 Mellanprodukter av dinukleotid- och oligonukliatidanaloger

Country Status (10)

Country Link
US (1) US5952478A (sv)
EP (1) EP0778843A1 (sv)
JP (1) JPH10506621A (sv)
AU (1) AU695607B2 (sv)
CA (1) CA2198900A1 (sv)
FI (1) FI970765A (sv)
GB (1) GB9417746D0 (sv)
HU (1) HUT76857A (sv)
NO (1) NO970870L (sv)
WO (1) WO1996008503A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US6639061B1 (en) 1999-07-07 2003-10-28 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate oligomers and related compounds
GB9604669D0 (en) 1996-03-05 1996-05-01 Ciba Geigy Ag Chemical compounds
GB9612600D0 (en) 1996-06-13 1996-08-21 Ciba Geigy Ag Chemical compounds
US6414135B1 (en) 1999-07-07 2002-07-02 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate monomers and related compounds
US8324179B2 (en) * 2007-02-09 2012-12-04 Gilead Sciences, Inc. Nucleoside analogs for antiviral treatment
GEP20156313B (en) 2010-09-22 2015-07-10 Alios Biopharma Inc Substituted nucleotide analogs
EP2794630A4 (en) 2011-12-22 2015-04-01 Alios Biopharma Inc SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
CN104321333A (zh) 2012-03-21 2015-01-28 沃泰克斯药物股份有限公司 硫代氨基磷酸酯核苷酸前药的固体形式
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3307744A1 (de) * 1983-03-04 1984-09-06 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig 2'-desoxy-3'-phosphonylmethyl-nucleoside
DE4037363A1 (de) * 1990-04-09 1991-10-10 Europ Lab Molekularbiolog 2-0-alkylnukleotide sowie polymere, die solche nukleotide enthalten
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
GB9304618D0 (en) * 1993-03-06 1993-04-21 Ciba Geigy Ag Chemical compounds
GB9311682D0 (en) * 1993-06-05 1993-07-21 Ciba Geigy Ag Chemical compounds

Also Published As

Publication number Publication date
AU695607B2 (en) 1998-08-20
NO970870D0 (no) 1997-02-26
GB9417746D0 (en) 1994-10-19
WO1996008503A1 (en) 1996-03-21
EP0778843A1 (en) 1997-06-18
HUT76857A (en) 1997-12-29
CA2198900A1 (en) 1996-03-21
US5952478A (en) 1999-09-14
FI970765A (sv) 1997-04-25
JPH10506621A (ja) 1998-06-30
NO970870L (no) 1997-04-17
AU3229695A (en) 1996-03-29

Similar Documents

Publication Publication Date Title
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
NO993068L (no) Ny forbindelsesform
LV11983A (lv) Iekskigi lietojams 2-metil-tieno-benzodiazepina zalu preparats
MA26668A1 (fr) ACTIVATEURS DE hPPARy ET hPPARa
DE69737044D1 (de) Herstellung von fugizides Chinazolinonen und nützliche Zwischenprodukte
FI980246A (sv) Förfarande för driften av en kokare och kokare
FI965204A0 (sv) Medicinsk användning av bromelain
LV12259A (lv) Jauna r-alfa-propilpiperonilamina un ta analogu asimetriska sinteze
FI970765A0 (sv) Mellanprodukter av dinukleotid- och oligonukliatidanaloger
ZA977619B (en) Naphthyl compounds intermediates compositions and methods of use
ID16838A (id) Komposisi dekafluoropentana
IL134210A0 (en) Use of transcription factor brn-3a
FI950454A (sv) Enzymatisk acyllering av 3-hydroximetylcefalosporiner
FI942576A0 (fi) Behandling av plasma
ID17419A (id) Komposisi dekafluoropentana
DE69713192T2 (de) Kombination von Enzymen
FI971378A (sv) Förfaranden och mellanprodukter för framställning av 3-aminobenso(b)azepinoner
KR970057129U (ko) 어태치먼트의 착탈구조
DE69706786T2 (de) Herstellung von Norlabdan-Oxid-Zwischenprodukten
KR960011685U (ko) 조명등 결합구조
KR950024188U (ko) 갈치주낚용 도래의 고정구
KR960023536U (ko) 부재의 체결구조
KR960020995U (ko) 햇빛가리개의 구조
KR960012387U (ko) 브라운관의 배기로
SE9602592D0 (sv) Ny användning av etylklorid